2-Methyl-N-[(6-(5-(4-[(3-methylbut-2-en-1-yl)oxy]phenyl)oxazol-2-yl)pyridin-3-yl)methyl]propan-1-amine

ID: ALA4063779

PubChem CID: 137634648

Max Phase: Preclinical

Molecular Formula: C24H29N3O2

Molecular Weight: 391.52

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)=CCOc1ccc(-c2cnc(-c3ccc(CNCC(C)C)cn3)o2)cc1

Standard InChI:  InChI=1S/C24H29N3O2/c1-17(2)11-12-28-21-8-6-20(7-9-21)23-16-27-24(29-23)22-10-5-19(15-26-22)14-25-13-18(3)4/h5-11,15-16,18,25H,12-14H2,1-4H3

Standard InChI Key:  RQPWLALVJUDTKJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
    2.7057   -7.9388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4215   -8.3513    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1331   -7.9388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8490   -8.3513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5648   -7.9388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5648   -7.1139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8490   -6.7014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1331   -7.1139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0308   -7.0390    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5840   -6.4268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1715   -5.7109    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3655   -5.8833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2807   -6.7014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4043   -6.5140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7356   -7.2687    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.5551   -7.3562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0418   -6.6890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7030   -5.9321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8844   -5.8482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8622   -6.7751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1978   -7.5287    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7086   -8.1943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0409   -8.9454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8613   -9.0358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9916   -8.3519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2767   -7.9400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5706   -8.3531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2761   -7.1151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5535   -9.6111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  3  8  2  0
  2  3  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  9 13  1  0
  6 13  1  0
  1  2  1  0
 10 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 14  2  0
 17 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
  1 25  1  0
 25 26  2  0
 26 27  1  0
 26 28  1  0
 23 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4063779

    ---

Associated Targets(Human)

SUM185PE (35 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-453 (1139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC1806 (544 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC1937 (423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-549 (31254 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

A10 (235 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 391.52Molecular Weight (Monoisotopic): 391.2260AlogP: 5.49#Rotatable Bonds: 9
Polar Surface Area: 60.18Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.20CX LogP: 4.68CX LogD: 2.89
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.49Np Likeness Score: -0.48

References

1. Robles AJ, McCowen S, Cai S, Glassman M, Ruiz F, Cichewicz RH, McHardy SF, Mooberry SL..  (2017)  Structure-Activity Relationships of New Natural Product-Based Diaryloxazoles with Selective Activity against Androgen Receptor-Positive Breast Cancer Cells.,  60  (22): [PMID:29053266] [10.1021/acs.jmedchem.7b01228]

Source